So much for deflating health care costs.
U.S. spending on specialty prescription drugs — those used to treat chronic and complex diseases such as cancer, multiple sclerosis and rheumatoid arthritis — is likely to increase 67 percent by the end of 2015, according to data from Express Scripts.
The pharmacy benefits manager said the increase in spending over the next three years is mostly due to a large number of drugs under development and doctors delaying treatment of patients until they're on the market.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
